Mitoxantrone Recruiting Phase 3 Trials for Childhood Myelodysplastic Syndrome / Childhood Acute Myeloid Leukemia / Myelodysplastic Syndrome / Blasts 5 Percent or More of Bone Marrow Nucleated Cells / Cytopenias / Leukemia Acute Myeloid Leukemia (AML) / Myeloid Leukemia Associated With Down Syndrome / Down Syndrome (DS) / Myeloproliferative Neoplasms / Trisomy 21 Mosaicism Treatment

RecruitingTreatment3 IdentifierTitleDrugs
NCT02521493Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
NCT03926624Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd Salvage
NCT02461537Impact of Remission Induction Chemotherapy Prior to Allogeneic SCT in Relapsed and Poor-response Patients With AML
NCT03257241A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old
NCT02072811Role of the Therapy Tailored to Risk Factors in Treating Adult Patients (≤60) With Acute Myeloid Leukemia
NCT02724163International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia